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Abstract
Aims: Epidemiological studies suggest that sex has a role in the pathogenesis of cardioembolic stroke. Since stroke is a
vascular disease, identifying sexually dimorphic gene expression changes in blood leukocytes can inform on sex-specific risk
factors, response and outcome biology. We aimed to examine the sexually dimorphic immune response following
cardioembolic stroke by studying the differential gene expression in peripheral white blood cells.
Methods and Results: Blood samples from patients with cardioembolic stroke were obtained at #3 hours (prior to
treatment), 5 hours and 24 hours (after treatment) after stroke onset (n = 23; 69 samples) and compared with vascular risk
factor controls without symptomatic vascular diseases (n = 23, 23 samples) (ANCOVA, false discovery rate p#0.05, |fold
change| $1.2). mRNA levels were measured on whole-genome Affymetrix microarrays. There were more up-regulated than
down-regulated genes in both sexes, and females had more differentially expressed genes than males following
cardioembolic stroke. Female gene expression was associated with cell death and survival, cell-cell signaling and
inflammation. Male gene expression was associated with cellular assembly, organization and compromise. Immune
response pathways were over represented at #3, 5 and 24 h after stroke in female subjects but only at 24 h in males.
Neutrophil-specific genes were differentially expressed at 3, 5 and 24 h in females but only at 5 h and 24 h in males.
Conclusions: There are sexually dimorphic immune cell expression profiles following cardioembolic stroke. Future studies
are needed to confirm the findings using qRT-PCR in an independent cohort, to determine how they relate to risk and
outcome, and to compare to other causes of ischemic stroke.
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Introduction
Experimental, clinical and epidemiological evidence points to
sexual dimorphism in stroke for: risk factors, age, heritability,
causes, outcomes and response to treatment [1,2] For example,
females have more cardioembolic stroke, while men have more
large-vessel and lacunar stroke [3,4]. The heritability of stroke is
higher in females than males [2]. Sex differences in response to
thrombolysis and functional outcome have also been suggested
[5,6]. Hormonal as well as non-hormonal mechanisms have been
proposed for these sex differences [1,7,8].
We have previously investigated the sexually dimorphic
immune response in blood of patients with acute ischemic stroke
[9–13]. The current study investigates the sex differences in gene
expression in the peripheral immune system following cardioem-
bolic stroke, a major cause of stroke. We hypothesized that some of
the sex differences in cardioembolic stroke relate in part to
differences of cell death, coagulation and inflammatory pathways
in peripheral leukocytes. We found more regulated genes in
females than in males and found differences in time course of
expression of neutrophil–specific genes in females compared to
males following cardioembolic stroke.
Materials and Methods
Study protocols were approved by the institutional review
boards (IRB) at each site (University of California at Davis and
University of Cincinnati) and written informed consent was
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obtained from each patient. Detailed methods, including diagnosis
of cardioembolic stroke and analysis details, are provided in File
S1. In brief, whole blood from subjects with cardioembolic stroke
was collected at three time points following stroke (n = 23, 11
female, 12 male; 69 samples). Treatment [14] was initiated within
3 hours of onset in all studied stroke patients. The first blood
sample was drawn before treatment (tPA treatment alone, or in
combination with eptifibatide therapy) (#3 hours). After treat-
ment, two blood samples were drawn at 5 hours and 24 hours
after the stroke. The vascular risk factor controls (VRFC) (n = 23;
11 female, 12 male) were subjects with no history of symptomatic
vascular disease [15].
Gene expression was analyzed on Affymetrix U133 Plus 2.0
whole-genome expression arrays as a function of diagnosis, age,
race, sex, batch and sex-by-diagnosis interaction using ANCOVA.
Genes with false discovery rate (FDR)-corrected P#0.05 (multiple
comparison correction) and |fold change| $1.2 were considered
differentially expressed. An additional ANOVA model accounted
for vascular risk factors (VRFs = atrial fibrillation, diabetes,
hyperlipidemia, hypertension). Genes significant for any VRF (p,
0.005) were excluded. For the analysis, females with cardioembolic
stroke were compared with female vascular risk factor controls
(VRFC), and males with cardioembolic stroke were compared
with male VRFC. Thus female stroke and control subjects were
compared to each other, and male stroke and control subjects were
compared to each other to minimize the effect of genes with sex-
associated expression. A Fisher’s Exact test, a Chi-square test and
a t-test were performed for the demographic and clinical
characteristics, and a p,0.05 was considered a significant
difference. The data from this study have been deposited in
GEO, accession number GSE58294.
Results
Subject Demographics
Subjects’ characteristics are presented in Table 1. Age was not
statistically significantly different between male and female strokes,
nor between male and female controls (VRFC). Age was
significant between stroke and VRFC males (P=1.2E-05), and
between stroke and VRFC females (P=7E-04). Race was not
significant between stroke and VRFC males, stroke and VRFC
females, and female and male VRFCs. Race was significant
between female and male stroke subjects (P=9.4E-03). No VRFs
are significantly different between female and male stroke subjects,
and between female and male VRFCs. Across the groups, the only
significant differences were female stroke vs VRFC for atrial
fibrillation (p = 1.2E-02), and male stroke vs VRFC for hyperlip-
idemia (p = 3.9E-02). As noted above, we controlled for the
differences in VRF by including them in the ANCOVA model,
and by excluding genes significant for any of the VRFs. NIH
Stroke Scale (NIHSS) was not significantly different between
female and male stroke patients (Table 1).
Sexual dimorphism ,3 h following cardioembolic stroke
(prior to treatment)
The results and discussion focus on this time point because
subjects received no treatment prior to this blood draw. A total of
788 genes (1,118 probe sets) were differentially expressed in
females with stroke compared to VRFC females, and 94 genes
(140 probe sets) were differentially expressed in males with stroke
compared to VRFC males. Of the 788 and 94 genes, 717 were
female-specific, 23 were male-specific, and 71 genes were common
to both sexes (Table S1 in File S2). Generally, many more genes
were up regulated rather than down regulated in both sexes; and
more genes were regulated in females compared to males
(Figure 1A).
There were 14 over-represented canonical pathways (Benja-
mini-Hochberg FDR corrected P,0.05) in females (in the 788
female genes) (Table S2 in File S2), the top five of which are
presented in Table 2. No canonical pathway at #3 h in males (in
the 94 male genes) passed the FDR corrected P-value threshold.
The highest scoring Network in females was Cell Death,
Survival, Assembly and Organization, which was similar to males
with Cellular Assembly, Organization and Compromise (Figure S1
in File S1). The top Disease and Functions annotation in females
was inflammatory response, including several neutrophil processes,
such as influx, recruitment, cell movement, and homing;
phagocytosis of blood cells, chemotaxis of phagocytes, and
phagocytosis and chemotaxis of myeloid cells. These processes
were predicted to be significantly increased (P,3.9610203;
activation z-score.2) according to Ingenuity Pathway Analysis
(IPA) knowledge-based predictions (see Table S3 in File S2). See
Supplementary Material for how Z score and statistical signifi-
cance were calculated. The Disease and Functions IPA annota-
tions with the highest activation z-score for the 94 differentially
expressed genes in males was Development of Blood Vessels and
Vasculogenesis (P = 0.03; z-score = 1.8) (see Table S3 in File S2).
Based on the expression of the genes in males, the transcription
factor XBP1 was predicted to be activated (P = 0.0003, activation
z-score = 2.2), while in females predicted transcriptional regulators
included XBP1, NFKBIA, KLF5, EIF4E and HIF1A (hypoxia
inducible factor 1, alpha subunit) (P = 0.01; activation z-score.2)
(see Table S4 in File S2). Xbp1 is involved in the unfolded protein
response to cell stress, NFKBIA regulates oxidative stress
responsive genes, EIF4E regulates translation, and HIF1A
regulates hypoxia responsive target genes. Genes differentially
expressed only in male or only in female cardioembolic strokes are
presented in Table S1 in File S2. Figure 2 represents over-
represented Functions and Disease Categories in these female- and
male-specific gene lists at #3 hours following cardioembolic
stroke. There are several Functions common to both sexes
(Figure 2).
Sexual dimorphism at 5 h following cardioembolic stroke
A total of 1,972 genes (2,937 probe sets) were differentially
expressed in females with stroke compared to VRFC females, and
226 genes (304 probe sets) were differentially expressed in males
with stroke compared to VRFC males (see Table S1 in File S2). Of
these genes, 1,758 were female-specific, 12 were male-specific, and
214 were common to both sexes (see Table S1 in File S2).
Figure 1B describes the numbers of up-regulated and down-
regulated stroke genes compared to the VRFC. The over-
represented canonical pathways (Benjamini-Hochberg P,0.05)
in female are presented in Table 2 (top 5) and Table S2 in File S2.
No canonical pathway at 5 h in males passed the FDR corrected
P-value threshold.
The highest scoring network in females was Cell-to-Cell
Signaling and Interaction and Inflammatory Response, while in
males it was Post-Translational Modification, DNA Replication,
Recombination, and Repair. The top Disease and Functions
annotations for the 1,972 differentially expressed genes in females
(activation z-scores.2) were infectious disease, protein transport,
leukocyte development, polarization of macrophages, T cell
development/homeostasis, RNA induction, polarization of anti-
gen presenting cells, engulfment by macrophages, and response/
influx of macrophages; whereas in males it was proliferation of
cells and transcription (see Table S3 in File S2). Genes
Sexual Dimorphism in Cardioembolic Stroke
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differentially expressed only in male or only in female cardioem-
bolic stroke subjects at 5 h are presented in Table S1 in File S2.
Sexual dimorphism at 24 h following cardioembolic
stroke
At 24 hours post-stroke, 3,213 genes (5,161 probe sets) were
differentially expressed in females with stroke compared to VRFC
females, and 1,070 genes (1,474 probe sets) were differentially
expressed in males with stroke compared to VRFC males (see
Table S1 in File S2). Of these genes, 2,362 were female-specific,
219 were male-specific, and 851 were common to both sexes (see
Table S1 in File S2). The over-represented canonical pathways at
24 h in females and males are presented in Table 2 (top 5) and
Table S2 in File S2.
The highest scoring network in females was post-translational
modification, humoral immune response and protein synthesis;
while in males it was RNA post-transcriptional modification,
cardiovascular disease and cell cycle. The top Disease and
Functions in females were cell death and survival, response to
phagocytes, engulfment by macrophages, chemotaxis of neutro-
phils, recruitment and response of phagocytes, differentiation of
antigen presenting cells, T cell development and homeostasis and
cardiovascular system function processes; while in males it was
chemotaxis, homing and cytotoxicity of leukocytes, and quantity of
T lymphocytes (see Table S3 in File S2). Genes differentially
expressed only in male or only in female cardioembolic stroke
subjects at 24 h are presented in Table S1 File S2.
Sexually dimorphic cell-specific response to
cardioembolic stroke
We next investigated transcripts expressed in just one blood cell
type. To do this we compared our gene lists with the Haem Atlas
gene lists [16]. We calculated the percentages of regulated cell-
specific transcripts (transcripts uniquely expressed in only one cell
type) in our gene lists and plotted them on the Y axis in Figure 3.
The percentage was calculated as the number of transcripts
differentially expressed at each time point for each sex (our gene
lists) that are known to be specific for each cell type (based on
overlap with the Haem Atlas cell-specific transcripts) divided by
the total number of transcripts in each of our gene lists. Since the
numbers of lineage-specific genes vary greatly for each cell type
(752 unique for neutrophils, 190 for monocytes, 262 for
megakaryocytes, 210 for B cells, 303 for erythroblasts, 44 for
helper T cells and 74 for Natural Killer cells) [16], the percent of
transcripts from our gene lists that overlap with the cell-type
specific transcripts is greatly influenced by these numbers. A t-test
for significant differences between percents was used to test for
significant differences between the sexes and times. The data show
the percents of neutrophil-specific transcripts were over-represent-
ed in the gene lists at #3, 5 and 24 h in females but only at 5 h
and 24 h in males (Figure 3). The data also show significant
Table 1. Subject characteristics.
Vascular Risk Factor Controls Cardioembolic Stroke Patients
Total Male Female Total Male Female
Subjects, no. 23 12 11 23 12 11
Age, years (mean6SD) 57.963.3 56.863.6 59.162.6 71.767.9 72.167.6 71.368.5
Q1 55.0 53.8 56.5 69.1 71.0 63.4
Median 58.0 56.0 61.0 74.9 74.2 68.1
Q3 61.0 60.3 61.0 77.5 77.0 77.3
Race
White, no. (%) 19 (82.6) 11 (91.7) 8 (72.7) 15 (65.2) 11 (91.7) 4 (36.4)
Nonwhite, no.(%) 4 (17.4) 1 (8.3) 3 (27.3) 8 (34.8) 1 (8.3) 7 (63.6)
Hyperlipidemia, no. (%) 16 (69.6) 9 (75) 7 (63.6) 6 (26.1) 3 (25.0) 3 (27.3)
Hypertension, no. (%) 16 (69.6) 9 (75) 7 (63.6) 16 (69.6) 8 (66.7) 8 (72.7)
Diabetes, no. (%) 5 (21.7) 3 (25.0) 2 (18.2) 4 (17.4) 2 (16.7) 2 (18.2)
Atrial fibrillation, no. (%) 0 (0) 0 (0) 0 (0) 9 (39.1) 3 (25.0) 6 (54.5)
NIHSS, ,3 h N/A N/A N/A 15.4 15.0 15.9
Q1 10.0 8.3 11.5
Median 13.0 13.5 13.0
Q3 20.0 20.3 18.5
NIHSS, 5 h N/A N/A N/A 11.9 11.7 12.0
Q1 5.8 6.5 6.5
Median 9.5 10.0 9.0
Q3 16.0 14.0 15.0
NIHSS, 24 h N/A N/A N/A 11.2 10.2 12.3
Q1 3.5 3.0 4.5
Median 10.0 10.0 12.0
Q3 16.0 13.5 18.0
doi:10.1371/journal.pone.0102550.t001
Sexual Dimorphism in Cardioembolic Stroke
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Figure 1. Genes differentially expressed in female and male following cardioembolic stroke. * -genes with female-specific expression;
** -genes with male-specific expression.
doi:10.1371/journal.pone.0102550.g001
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percentages of monocyte-specific transcripts in females at #3 h
and 24 h, and decreases in percentages of megakaryocyte and
erythrocyte genes from #3 h to 24 h in males (Figure 3). The
changes for the other cell types were not statistically significant
(Figure S2 in File S1). Since we measured gene expression in whole
blood (containing different cell types), the only way to deduce cell-
Table 2. Top five over-represented canonical pathways in cardioembolic stroke; Benjamini-Hochberg P-value ,0.05.
Females, #3 h following cardioembolic stroke Females, 5 h following cardioembolic stroke
1. Toll-like Receptor Signaling 1. Toll-like Receptor Signaling
2. PPARa/RXRa Activation 2. B cell Receptor Signaling
3. Hypoxia Signaling in the Cardiovascular System 3. Role of JAK Family Kinases in IL-6-type Cytokine Signaling
4. TREM1 Signaling 4. EGF Signaling
5. IL-10 Signaling 5. IL-22 Signaling
Females, 24 h following cardioembolic stroke Males, 24 h following cardioembolic stroke
1. B Cell Receptor Signaling 1. B Cell Receptor Signaling
2. Toll-like Receptor Signaling 2. Toll-like Receptor Signaling
3. NF-kB Signaling 3. Fcc Receptor-mediated Phagocytosis in Macrophages and Monocytes
4. EIF2 Signaling 4. T Cell Receptor Signaling
5. Fcc Receptor-mediated Phagocytosis in Macrophages and Monocytes 5. FGF Signaling
doi:10.1371/journal.pone.0102550.t002
Figure 2. Over-represented categories in the female-specific and/or male-specific genes regulated at #3 hours following
cardioembolic stroke. Categories above the orange line are significant at Benjamini-Hochberg corrected P-value ,0.05.
doi:10.1371/journal.pone.0102550.g002
Sexual Dimorphism in Cardioembolic Stroke
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type specific expression for this sub-analysis is by looking at
transcripts unique to a particular blood cell type, based on the
HaemAtlas transcript catalogue. Thus, as an example, the lack of
monocyte-specific genes differentially expressed at #3 h in males
does not mean that monocytes in males did not have differentially
expressed genes at this time point – it just means there were no
‘‘monocyte-specific’’ genes.
Discussion
Gene expression following cardioembolic stroke showed com-
mon and sex-specific changes. There were more up-regulated than
down-regulated genes in both sexes and more genes regulated in
females than in males, in line with previous studies [11,12]. The
findings point to sexual dimorphism of cell death, cell survival,
inflammation, and coagulation pathways in peripheral blood and
support our previous findings of an important role for neutrophils
in cardioembolic stroke [9,10,17], which we show here is sexually
dimorphic.
Early immune response following cardioembolic stroke
(#3 h, untreated)
Female response. A number of interconnected pathways
(Figure S3 in File S1) previously associated with ischemic stroke
were over-represented in females, including TLR (Toll-like
receptor), HMGB1, TREM1, PPARa/RXRa, Hypoxia, Renin-
Angiotensin, Mitochondrial Dysfunction, Glucocorticoid receptor
and cytokine signaling pathways [12,18]. TLR Signaling was the
top over-represented pathway at all three time points in females
(but only at 24 h in males). It plays a pivotal role in stroke and
preconditioning and serves as a link between the central nervous
system and periphery after stroke. TLR2,5,8, MYD88, and a
number of TLR modulators – IRAK1, MEKK1, NIK,
p38MAPK, NF-kB, MKK3/6 were up regulated in females, most
having been implicated in ischemic brain injury [19]. Toll-like
receptors have a number of downstream effects following cerebral
ischemia, including MyD88-directed activation of neutrophil
chemoattractants [20], and this process was predicted to be
increased in females in this study. In addition, HMGB1 (high-
mobility group protein B1), released by injured endothelial and
Figure 3. Cell-type specific gene expression in female and male following cardioembolic stroke. Y-axis - % of genes from our gene list,
which overlap with a cell-type specific gene list from Watkins et al, 2007. * p,0.05; **P,0.005;# hypergeometric probability of overlap between our
gene list and the cell-type specific gene list from Watkins et al, 2007,0.05; ‘ Watkins et al used positive selection, therefore granulocyte population
consisted of three cell types (neutrophils, eosinophils, and basophils), all of which expressed CD66b and would have therefore been co-purified.
However, the neutrophils are the largest percent.
doi:10.1371/journal.pone.0102550.g003
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other cells following ischemic stroke, activates TLR2/4 which
leads to ROS generation and cytokine production [21].
Male response. The highest scoring network in males at 3 h
had convergent nodes on CREB, Caspase-1, and ERK1/2, all
having been implicated in stroke (Figure S3 in File S1). Cerebral
ischemia triggers phosphorylation of CREB and subsequent CRE-
mediated gene expression in neurons, which leads to expression of
genes encoding neuroprotective molecules [22]. CASP1 is
involved in forming the inflammasome and initiating inflamma-
tion via activation of IL-1b. A number of transcriptional regulators
belonged to this network including YY1, SMARCA4, HNRNPD,
TRIM27 and ATRX. The YY1 transcription factor modifies
histones by directing histone deacetylases and acetyltransferases to
activate or repress promoter sites. SMARCA4 (SWI/SNF related,
matrix associated, actin dependent regulator of chromatin,
subfamily a, member 4) is part of the SNF/SWI complex and
regulates transcription by altering the chromatin structure around
specific genes. HNRNPD (heterogeneous nuclear ribonucleopro-
tein D (AU-rich element RNA binding protein 1, 37 kDa)
regulates mRNA stability. These findings may suggest that
different epigenetic mechanisms are involved in the early response
to stroke in males, one possible explanation for the smaller number
of differentially expressed genes in males compared to females.
These differences in the immune response by 3 hours after stroke
in males and females suggest differences in clotting and/or the
immune response to the ischemic brain injury and may contribute
to the sexually dimorphic features of cardioembolic stroke [23].
Cell Death Pathways in Peripheral Blood Following
Cardioembolic Stroke
Brain cell death and apoptosis pathways are sexually dimorphic
in experimental stroke models [24], with females often showing
caspase-mediated cell death of neurons whereas males predomi-
nantly undergo caspase-independent cell death [8]. Notably, in
our previous study of human peripheral blood leukocytes following
ischemic stroke, we also observed sexually dimorphic cell death
pathways with females showing Caspase 1, HMGB1, and NFkB
Signaling pathways, while in males Granzyme A signaling and
other cell death molecules were involved [12]. Similarly in the
current study at #3 hours following cardioembolic stroke, we
observed 217 molecules involved in cell death in females, such as
CASP1 (caspase1), IRAK3, CREB1, HMGB1, CARD11, NFkB1,
BCL2A1, ITGAM (integrin, alpha M), TLR2, INRAF1 (interfer-
on (a, b, c) receptor 1), STAT5B (signal transducer and activator
of transcription 5), CD44, CD59, and MYD88. ITGAM is
important in adherence of neutrophils and monocytes to
stimulated endothelium, and also in the phagocytosis of comple-
ment coated particles. ITGAM regulates ICAM1, Fibrinogen,
TNF, IL6, ITGB2, NFkB, IL1B, CYR61, STAT3, MAPK3,
MAPK1, IFNB1, C3 and superoxide - all of which have been
implicated in ischemic brain injury [7]. These molecules belonged
to TLR receptor, HMGB1, NFkB, TREM1 and other signaling
pathways (Table S2 in File S2). In addition, Apaf-1 (apoptotic
associated factor 1), FADD (Fas (TNFRSF6)-associated via death
domain) and Bcl-2, up regulated in female cardioembolic stroke,
have all been associated with female cell death following stroke [7].
In contrast, 22 molecules were involved in cell death in males at
#3 hours, including NOA1 (nitric oxide associated 1), TRAF7
(TNF receptor-associated factor 7, E3 ubiquitin protein ligase),
and several transcriptional regulators (ATRX, SMARCA4,
TFDP1, TRIM27, YY1). NOA1 is involved in regulation of
mitochondrial protein translation and respiration. It plays a role in
mitochondria-mediated cell death. TRAF7 is a signal transducer
for members of the TNF receptor superfamily, which are death
receptors in the extrinsic apoptosis pathway. Notably, 18 out the
22 male cell death genes at #3 hours were among the 217 female
cell death genes. These and previous results [7,8,25] suggest
common and divergent pathways of cell death in males and
females. Though the cell death genes discovered here relate to
peripheral blood leukocytes and other cells, they are important
since they are being expressed in peripheral blood cells that
interact with and/or enter brain, and might relate to endogenous
immune responses of brain in cells like microglia which are very
much like blood monocytes.
Coagulation System
Clotting is important in the pathogenesis of human strokes.
Transcripts of many coagulation factors and platelet activating
genes increased in both sexes, though most with different temporal
profiles. F5 (coagulation factor V) was increased at all three time
points in females, while only at 24 h in males. F12 (coagulation
factor XII, Hageman factor), which increased both in males and
females at the later time points, initiates the intrinsic pathway of
coagulation and together with the extrinsic pathway forms fibrin.
F5 has been consistently implicated in stroke, while F12’s
involvement has recently been elucidated [26]. Another gene
involved in the clotting cascade, GP1BB (glycoprotein Ib (platelet),
beta polypeptide) was up regulated only in females at 24 h
following cardioembolic stroke. GP1BB is part of the GPIb-V-IX
system that constitutes the receptor for von Willebrand factor
(VWF) and mediates platelet adhesion in the arterial circulation.
PAFAH1B1 (platelet-activating factor acetylhydrolase 1b, reg-
ulatory subunit 1 (45 kDa)) and PAFAH1B2 (platelet-activating
factor acetylhydrolase 1b, catalytic subunit 2 (30 kDa)) also show
sexually dimorphic expression being regulated at all three time
points in females but only at later time points in male
cardioembolic strokes. This sex difference in the coagulation
system suggests it can have implications for risk factors,
progression of ischemic injury, outcome and response to
treatment. Treatment with tPA causes fibrinolysis of blood clots
and improves outcomes. However, sexual dimorphism in response
to tPA treatment has been suggested [5,6]. Thus, since the clot is
an important clinical target, consideration for a sexually dimorphic
coagulation system should be considered in animal and clinical
studies in stroke.
Female-specific Inflammatory Response
Inflammatory response pathways were associated with female-
specific genes at #3 hours after cardioembolic stroke (Figure 2).
This included predicted increase in several biological processes,
such as recruitment, homing, chemotaxis and influx of neutrophils,
immune response by phagocytes, immune response by antigen
presenting cells and antimicrobial and antiviral response. Inflam-
mation and infection are linked to stroke risk and outcome, with
some evidence for sexual dimorphism (reviewed in [27–29]). The
immune system can contribute to risk of stroke and to damage
and/or to repair processes following stroke (reviewed in [27–29]).
These sex differences could also contribute to some of the sexual
dimorphic features of stroke, such as age at stroke, response to
treatment and outcome [30]. In addition, both inflammatory and
anti-inflammatory pathways are enriched in female at ,3 h
following stroke. Though other possible explanations exist, it is
plausible that one reason for this complex response is different cell
types in the blood are mounting different immune responses.
Sexual Dimorphism in Cell-Type Specific Gene Expression
The cell-specific transcriptional changes of immune cells in
blood following cardioembolic stroke differed in males and
Sexual Dimorphism in Cardioembolic Stroke
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females, with neutrophil-specific genes being the most predomi-
nantly expressed genes at #3 h, 5 h and 24 h in females, while
males showed changes at 5 h that increased at 24 h. These
findings support our previous findings where genes regulated in
cardioembolic stroke were found to be associated more with
neutrophils, while the ones regulated in large-vessel atherosclerotic
stroke were associated more with platelets and Monocytes [10].
Neutrophils, the most abundant cell type in human blood, are
involved in response to infectious stimuli and non-infectious
inflammation [19]. They migrate to the site of inflammation or
injury where they remove dead cells and release inflammatory
molecules [19]. In stroke they have recently been shown to have
important roles in clotting and atherosclerosis [31]. Moreover,
increased numbers of neutrophils in blood have been correlated
with the risk of having an ischemic stroke and myocardial
infarction as well as correlating with poor outcomes and increased
mortality [32]. The greater percentage of neutrophil-specific
transcripts in females compared to males at early times following
stroke in this study could relate to biological functions associated
with the increased rate and morbidity of cardioembolic stroke in
females [30].
Of interest the percentage of megakaryocyte-specific transcripts
was highest at #3 h and decreased at later time points in males,
with no such temporal effects being observed in females.
Megakaryocytes are responsible for producing platelets, which
are needed for the formation of a blood clot. Sexually dimorphic
megakaryocyte responses may be associated with the suggested
differential benefit of anti-platelet therapy in males and females
[5].
Limitations
It is important to emphasize that though this is the first
description of gene expression changes in blood related to sex in
cardioembolic stroke, it is a pilot study with small sample size.
Future studies are needed to validate the findings using qRT-PCR
in an independent cohort. qRT-PCR was not performed here
since this is an initial study, but once the genes are biologically
validated in an independent cohort then they will be technically
validated using qRT-PCR in a future study. Some of the sexually
dimorphic gene expression differences may reflect pre-existing
differences not accounted for in our analyses. There were more
female than male stroke subjects with atrial fibrillation, and none
of the controls had asymptomatic atrial fibrillation; thus some of
the results could be due to sexual dimorphism related to atrial
fibrillation. In addition, differences in smoking, BMI, medications,
and other possible confounders could not be accounted for
because of the small number of subjects in this pilot study. Thus
some of the sexually dimorphic gene expression changes could be
due to these pre-existing baseline differences and not be associated
with the stroke response. The VRFC control subjects were
younger than the stroke subjects. We tried to account for this by
including age in the ANCOVA model, and by performing the
analyses across groups (Stroke vs. VRFC) for each sex, thus having
similar age-related bias in the male and female analyses.
Nevertheless, some of the observed differences could be age-
related. Since the 5 h and 24 h time points were collected after
treatment, and because we do not yet have untreated cardioem-
bolic stroke samples for these time points, we cannot estimate how
much of the dimorphic response is due to a sexually dimorphic
response to treatment at these time points [5,25]. Thus, the
discussion focused on the genes and pathways affected before
treatment at #3 hours. Since cardioembolic strokes were not
compared to other causes of stroke because of insufficient numbers
of subjects (males and females), future studies will be needed to
determine which of the sexually dimorphic changes identified here
are specific for cardioembolic stroke. Since this study only
examined gene expression changes between 3 and 24 h following
stroke, no expression data was available beyond 24 hours that
might also affect outcomes in men versus women following
cardioembolic stroke. Differences of hormone status of stroke
compared to control subjects were controlled for in part by
comparing female stroke to female controls and male stroke to
male controls. However, there are complex hormonal differences
between females with stroke compared to males with stroke that
likely affect gene expression and that relate in part to the post-
menopausal status of most of the women and declining testoster-
one levels in older men. Finally, this is an observational study and
though some of the differences may relate to different hormonal
status in males versus females, other causes for the differences
remain to be determined.
Conclusions
More genes are up regulated than down regulated following
cardioembolic stroke and more genes are regulated in females than
males. Sexually dimorphic gene expresison is noted for genes in
cell death and coagulation pathways and for genes specifically
expressed by neutrophils, monocytes and megakaryocytes follow-
ing cardioembolic stroke. This study provides additional evidence
for the sexually dimorphic nature of cardioembolic stroke.
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